Fineline Cube

Follow:
14398 Articles
Beijing Biostar Pharmaceuticals Set to Go Public on HKEX with Focus on Oncology Innovation
Company

Beijing Biostar Pharmaceuticals Set to Go Public on HKEX with Focus on Oncology Innovation

Akeso Biopharma Launches Phase Ib/II Trial for Cadonilimab and AK112 in Pancreatic Cancer
CompanyDrug

Akeso Biopharma Launches Phase Ib/II Trial for Cadonilimab and AK112 in Pancreatic Cancer

FDA Extends Review of Amgen's Lumakras for KRAS G12C mCRC Treatment to January 2025
CompanyDrug

FDA Extends Review of Amgen’s Lumakras for KRAS G12C mCRC Treatment to January 2025

Shenzhen Chipscreen Advances CS231295 for Cancer Treatment as IND Accepted by NMPA
CompanyDrug

Shenzhen Chipscreen Advances CS231295 for Cancer Treatment as IND Accepted by NMPA

Pfizer Partners with TRIANA Biomedicines to Develop Molecular Glue Degraders for Oncology and Other Diseases
CompanyDeals

Pfizer Partners with TRIANA Biomedicines to Develop Molecular Glue Degraders for Oncology and Other Diseases

AstraZeneca Files for Market Approval of Tremelimumab in China for Hepatocellular Carcinoma
CompanyDrug

AstraZeneca Files for Market Approval of Tremelimumab in China for Hepatocellular Carcinoma

MicroPort CardioFlow’s Heart Valve Balloon Dilatation Catheter Alwide Plus Gains Mexican Approval
CompanyMedical Device

MicroPort CardioFlow’s Heart Valve Balloon Dilatation Catheter Alwide Plus Gains Mexican Approval

Changshan Biochemical Pharmaceutical Wins Marketing Approval for Enoxaparin in Niger
CompanyDrug

Changshan Biochemical Pharmaceutical Wins Marketing Approval for Enoxaparin in Niger

Huahai Pharmaceutical Gets FDA Nod for Generic Empagliflozin and Metformin ANDA
CompanyDrug

Huahai Pharmaceutical Gets FDA Nod for Generic Empagliflozin and Metformin ANDA

Laekna Advances Obesity Treatment Candidate LAE102 with Subcutaneous Dosing in Phase I Study
CompanyDrug

Laekna Advances Obesity Treatment Candidate LAE102 with Subcutaneous Dosing in Phase I Study

Sanofi Invests EUR 300 Million in Joint Venture with Orano Med for Next-Generation Radioligand Therapies
CompanyDeals

Sanofi Invests EUR 300 Million in Joint Venture with Orano Med for Next-Generation Radioligand Therapies

Antengene's Xpovio Secures Expanded Access in South Korea for Multiple Myeloma Treatment
CompanyDrug

Antengene’s Xpovio Secures Expanded Access in South Korea for Multiple Myeloma Treatment